Abstract

Pulmonary hypertension is a serious clinical condition characterised by increased pulmonary arterial pressure. This can lead to right ventricular failure which can be fatal. Connexins are gap junction-forming membrane proteins which serve to exchange small molecules of less than 1 kD between cells. Connexins can also form hemi-channels connecting the intracellular and extracellular environments. Hemi-channels can mediate adenosine triphosphate release and are involved in autocrine and paracrine signalling. Recently, our group and others have identified evidence that connexin-mediated signalling may be involved in the pathogenesis of pulmonary hypertension. In this review, we discuss the evidence that dysregulated connexin-mediated signalling is associated with pulmonary hypertension.

Highlights

  • Pulmonary artery endothelial cells (PAECs), pulmonary artery smooth muscle cells (PASMCs) and pulmonary artery fibroblasts (PAFs) are all involved in the pulmonary vascular remodelling process

  • The increase in mean pulmonary arterial pressure observed in patients with Pulmonary Hypertension (PH) can be due to a variety of causes, PH can be sub-divided into five main clinical groups (Table 1): pulmonary arterial hypertension (PAH; group 1), PH due to left heart disease, PH due to chronic lung diseases or hypoxia, chronic thromboembolic

  • In vitro studies showed that the myoendothelial gap junctions (MEJ) between between rat PAECs and PASMCs were primarily formed by Cx43 [27]

Read more

Summary

Introduction

Pulmonary hypertension (PH) is defined by a chronic increase in mean pulmonary arterial pressure [1]. The increase in mean pulmonary arterial pressure observed in patients with PH can be due to a variety of causes, PH can be sub-divided into five main clinical groups (Table 1): pulmonary arterial hypertension (PAH; group 1), PH due to left heart disease (group 2), PH due to chronic lung diseases or hypoxia (group 3), chronic thromboembolic. Despite recent advances in our understanding of PH, current therapies serve only to prolong life and increase the quality of life. They are unable to reverse disease progression, and prognosis remains poor.

Overview of Connexins
Expression of Connexins in the Pulmonary Vasculature
Oestrogen-Induced Regulation of Connexin Expression
Connexin-Mediated Signalling in Pulmonary Vascular Reactivity
Connexin-Mediated Signalling in the Right Ventricle in Animal Models of PH
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.